| 000 | 01890 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517032116.0 | ||
| 264 | 0 | _c20160412 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1755-5922 | ||
| 024 | 7 |
_a10.1111/1755-5922.12132 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarcía-González, Martín J | |
| 245 | 0 | 0 |
_aLevosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study. _h[electronic resource] |
| 260 |
_bCardiovascular therapeutics _cAug 2015 |
||
| 300 |
_a193-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAortic Valve Stenosis _xdiagnosis |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCritical Illness |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdiagnosis |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazones _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyridazines _xadministration & dosage |
| 650 | 0 | 4 | _aRecovery of Function |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSimendan |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xdiagnosis |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aJorge-Pérez, Pablo | |
| 700 | 1 | _aJiménez-Sosa, Alejandro | |
| 700 | 1 | _aAcea, Antonio Barragán | |
| 700 | 1 | _aLacalzada Almeida, Juan B | |
| 700 | 1 | _aFerrer Hita, Julio J | |
| 773 | 0 |
_tCardiovascular therapeutics _gvol. 33 _gno. 4 _gp. 193-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1755-5922.12132 _zAvailable from publisher's website |
| 999 |
_c24886676 _d24886676 |
||